The Ethics Advisory Board (EAB) ensures that Illumina acts ethically and justly in its business operations. The EAB meets quarterly to advise and provide recommendations regarding ethical issues involving existing, emerging, and prospective products, services, and processes both from a research and clinical perspective. This includes providing strategic advice to Illumina regarding emerging ethical issues, policies, and regulations relevant to the genomics industry.